All three drugs are given as injections, and clinical trials have shown that theyre highly effective for weight loss
What about ANY of the cardiometabolic data for the 104 week extension arm, especially the 4mg max tolerated dose and the placebo arm MTD
Results demonstrated: Average weight loss: 14.9% of body weight Success rate breakdown: 86.4% lost at least 5% of body weight 69.1% lost at least 10% of body weight 50.5% lost at least 15% of body weight 32% lost at least 20% of body weight That same 220-pound person losing 14.9% would drop about 33 pounds to reach 187 pounds
Semaglutide vs Tesamorelin Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that targets visceral adipose tissue through a completely different mechanism
Peptide Therapy - GHRP-6. Revolution Health & Wellness , revolutionhealth.org/blogs/news/peptide-therapy-ghrp-6#:~:text=GHRP%2D6%20(5mg)%20is,GHRH%20to%20amplify%20GH%20secretion
While it has shown promise in reducing the risk of certain cardiovascular events, its use can also come with some side effects